Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH Reuters Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis PR Newswire Novo Nordisk’s obesity drug Wegovy cleared to treat MASH statnews.com Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH Yahoo Finance Novo Nordisk’s Wegovy Gets US Approval for …
Read More »